Diz osteoartriti bulunan hastalarda sinoviyal sıvılarındaki prostanoid düzeyleri ve ultrasonografik bulgular arasındaki ilişki

Amaç: Bu çalışmada, diz osteoartriti olan hastaların sinoviyal sıvılarındaki prostanoidlerin [tromboksan (TxA2) ve prostasiklin (PGI2)] düzeyi ile infrapatellar ve suprapatellar yağ yastığı kalınlığı ve diğer klinik parametreler arasındaki ilişkinin değerlendirilmesi amaçlanmıştır. Gereç ve Yöntem: Çalışmaya efüzyonlu diz osteoartriti bulunan 16 hasta dahil edilmiştir. Ağrı düzeyleri görsel analog skala (VAS) ile değerlendirilmiştir. Ağrı, sertlik ve fiziksel fonksiyon osteoartrit indeksi (WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index) ile değerlendirilmiştir. PGI2’nin kararlı metaboliti olan 6-keto-PGF1α ve TxA2’nin kararlı metaboliti olan TxB2 düzeyleri enzim immunoassay yöntemi ile ölçülmüştür. Bulgular: Sinoviyal sıvıda ölçülen 6-keto-PGF1α düzeyleri TxB2 düzeylerine göre anlamlı derecede yüksek bulunmuştur. TxB2 düzeyleri ile suprapatellar yağ yastığı kalınlığı ve TxB2/6-keto- PGF1α oranı ile kıkırdak kalınlığı arasında negatif korelasyon bulunmaktadır. Infrapatellar yağ yastığı kalınlığı ile suprapatellar yağ yastığı kalınlığı ve efüzyon hacmi arasında pozitif korelasyon bulunmaktadır. WOMAC değerleri ile VAS-aktivite ve VAS-gece skorları arasında pozitif korelasyon bulunmaktadır. Sonuç: 6-keto-PGF1α düzeylerine kıyasla, sinoviyal sıvı TxB2 düzeyleri osteoartritli hastalardaki ultrasonografik bulgular ile daha çok ilişkili bulunmuştur.

Association between synovial fluid prostanoid levels and ultrasonographic findings in knee osteoarthritis

Purpose. The aim of this study was to investigate the association between prostanoid [thromboxane (TxA2) and prostacyclin (PGI2)] levels in synovial fluid and infrapatellar fat pad (IPFP)/ suprapatellar fat pad (SPFP) thickness as well as other clinical findings in knee steoarthritis (OA) patients. Materials and Methods: 16 patients with knee OA with effusion were included. The average pain levels were evaluated using a Visual Analogue Scale (VAS). The pain, stiffness, and physical functions were evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). The levels of 6-keto-PGF1α, stable metabolite of PGI2, and TxB2, stable metabolite of TxA2, were measured in synovial fluid using an enzyme immunoassay. Results: 6-keto-PGF1α levels were significantly greater than TxB2 levels in synovial fluid of patients with OA. TxB2 levels and TxB2/6-keto- PGF1α ratio were negatively correlated with SPFP and cartilage thickness, respectively. IPFP thickness was positively correlated with SPFP thickness and effusion volume. WOMAC scores were positively correlated with VAS-activity and VAC-evening scores. Conclusion: In comparison to 6-keto- PGF1α levels in synovial fluid, TxB2 levels seem to be more associated with ultrasonographic findings in patients with OA.

___

  • 1. Hedbom E, Hauselmann HJ. Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell Mol Life Sci. 2002;59:45-53.
  • 2. Francin PJ, Abot A, Guillaume C, Moulin D, Bianchi A, Gegout-Pottie P et al. Association between adiponectin and cartilage degradation in human osteoarthritis. Osteoarthritis Cartilage. 2014;22:519- 26.
  • 3. Jevsevar DS. Treatment of Osteoarthritis of the Knee: Evidence-Based Guideline, 2nd edition. J Am Acad Orthop Surg. 2013;21:571-6.
  • 4. King LK, Henneicke H, Seibel MJ, March L, Anandacoomarasmy A. Association of adipokines and joint biomarkers with cartilage-modifying effects of weight loss in obese subjects. Osteoarthritis Cartilage. 2015;23:397-404.
  • 5. Gandhi R, Kapoor M, Mahomed NN, Perruccio AV. A comparison of obesity related adipokine concentrations in knee and shoulder osteoarthritis patients. Obes Res Clin Pract. 2015;9:420-3.
  • 6. Toda Y, Toda T, Takemura S, Wada T, Morimoto T, Ogawa R. Change in body fat, but not body weight or metabolic correlates of obesity, is related to symptomatic relief of obese patients with knee osteoarthritis after a weight control program. J Rheumatol. 1998;25:2181-6.
  • 7. Grotle M, Hagen KB, Natvig B, Dahl FA, Kvien TK. Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up. BMC Musculoskelet Disord. 2008;9:132.
  • 8. Han W, Cai S, Liu Z, Jin X, Wang X, Antony B et al. Infrapatellar fat pad in the knee: is local fat good or bad for knee osteoarthritis? Arthritis Res Ther. 2014;16:R145
  • 9. Chang J, Liao Z, Lu M, Meng T, Han W, Ding C. Systemic and local adipose tissue in knee osteoarthritis. Osteoarthritis Cartilage. 2018;26:864- 71.
  • 10. Clockaerts S, Bastiaansen-Jenniskens YM, Runhaar J, Van Osch GJ, Van Offel JF, Verhaar JA et al. The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthritis Cartilage. 2010;18:876-82.
  • 11. Han W, Aitken D, Zhu Z, Halliday A, Wang X, Antony B et al. Signal intensity alteration in the infrapatellar fat pad at baseline for the prediction of knee symptoms and structure in older adults: a cohort study. Ann Rheum Dis. 2016;75:1783-8.
  • 12. Pan F, Han W, Wang X, Liu Z, Jin X, Antony B et al. A longitudinal study of the association between infrapatellar fat pad maximal area and changes in knee symptoms and structure in older adults. Ann Rheum Dis. 2015;74:1818-24.
  • 13. Ozen G, Topal G, Gomez I, Ghorreshi A, Boukais K, Benyahia C et al. Control of human vascular tone by prostanoids derived from perivascular adipose tissue. Prostaglandins Other Lipid Mediat. 2013;107:13-7.
  • 14. Ozen G, Boumiza S, Deschildre C, Topal G, Longrois D, Jakobsson PJ et al. Inflammation increases MMP levels via PGE2 in human vascular wall and plasma of obese women. Int J Obes (Lond). 2019;43:1724-34.
  • 15. Mendizabal Y, Llorens S, Nava E. Vasoactive effects of prostaglandins from the perivascular fat of mesenteric resistance arteries in WKY and SHROB rats. Life Sci. 2013 18;93:1023-32.
  • 16. Awata WMC, Gonzaga NA, Borges VF, Silva CBP, Tanus-Santos JE, Cunha FQ et al. Perivascular adipose tissue contributes to lethal sepsis-induced vasoplegia in rats. Eur J Pharmacol. 2019;863:172706.
  • 17. Edin ML, Lih FB, Hammock BD, Thomson S, Zeldin DC, Bishop-Bailey D. Vascular Lipidomic Profiling of Potential Endogenous Fatty Acid PPAR Ligands Reveals the Coronary Artery as Major Producer of CYP450-Derived Epoxy Fatty Acids. Cells. 2020;9(5)
  • 18. Chang L, Villacorta L, Li R, Hamblin M, Xu W, Dou C et al. Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-gamma deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. Circulation. 2012;126:1067-78.
  • 19. Hodnett BL, Dearman JA, Carter CB, Hester RL. Attenuated PGI2 synthesis in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol. 2009;296:R715- 21.
  • 20. Sasaki Y, Kuwata H, Akatsu M, Yamakawa Y, Ochiai T, Yoda E et al. Involvement of prostacyclin synthase in high-fat-diet-induced obesity. Prostaglandins Other Lipid Mediat. 2020;153:106523.
  • 21. Goodwill AG, James ME, Frisbee JC. Increased vascular thromboxane generation impairs dilation of skeletal muscle arterioles of obese Zucker rats with reduced oxygen tension. Am J Physiol Heart Circ Physiol. 2008;295:H1522-8.
  • 22. Norel X, Sugimoto Y, Ozen G, Abdelazeem H, Amgoud Y, Bouhadoun A et al. International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions. Pharmacol Rev. 2020;72:910-68.
  • 23. Hishinuma T, Tsukamoto H, Suzuki K, Mizugaki M. Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications. Prostaglandins Leukot Essent Fatty Acids. 2001;65:191-6.
  • 24. McConnell S, Kolopack P, Davis AM. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthritis Rheum. 2001;45:453-61.
  • 25. Sen EI, Yildirim MA, Yesilyurt T, Kesiktas FN, Diracoglu D. Effects of platelet-rich plasma on the clinical outcomes and cartilage thickness in patients with knee osteoarthritis. J Back Musculoskelet Rehabil. 2020;33:597-605.
  • 26. Tüzün EH, Eker L, Aytar A, Daşkapan A, Bayramoğlu M. Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthritis Cartilage. 2005;13:28–33
  • 27. Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983;16:87-101.
  • 28. Gur G, Turgut E, Dilek B, Baltaci G, Bek N, Yakut Y. Validity and reliability of Visual Analog Scale Foot and Ankle: The Turkish version. J Foot Ankle Surg. 2017;56:1213-1217.
  • 29. Akkaya S, Akkaya N, Ozcakar L, Kilic A, Sahin F, Atalay NS et al. Ultrasonographic evaluation of the femoral cartilage thickness after unilateral arthroscopic partial meniscectomy. Knee Surg Sports Traumatol Arthrosc. 2013;21:1104-10.
  • 30. Ozcakar L, Tunc H, Oken O, Unlu Z, Durmus B, Baysal O et al. Femoral cartilage thickness measurements in healthy individuals: learning, practicing and publishing with TURK-MUSCULUS. J Back Musculoskelet Rehabil. 2014;27:117-24.
  • 31. Benabdoune H, Rondon EP, Shi Q, Fernandes J, Ranger P, Fahmi H et al. The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritis. Inflamm Res. 2016;65:635-45.
  • 32. Ma J, Niu DS, Wan NJ, Qin Y, Guo CJ. Elevated chemerin levels in synovial fluid and synovial membrane from patients with knee osteoarthritis. Int J Clin Exp Pathol. 2015;8:13393-8.
  • 33. Belluzzi E, El Hadi H, Granzotto M, Rossato M, Ramonda R, Macchi V et al. Systemic and Local Adipose Tissue in Knee Osteoarthritis. J Cell Physiol. 2017;232:1971-8.
  • 34. Kulkarni K, Karssiens T, Kumar V, Pandit H. Obesity and osteoarthritis. Maturitas. 2016;89:22-8.
  • 35. Egg D. Concentrations of prostaglandins D2, E2, F2 alpha, 6-keto-F1 alpha and thromboxane B2 in synovial fluid from patients with inflammatory joint disorders and osteoarthritis. Z Rheumatol. 1984;43:89-96.
  • 36. Bley KR, Hunter JC, Eglen RM, Smith JA. The role of IP prostanoid receptors in inflammatory pain. Trends Pharmacol Sci. 1998;19:141-7.
  • 37. Flower RJ. The development of COX2 inhibitors. Nat Rev Drug Discov. 2003;2:179-91.
  • 38. Pulichino AM, Rowland S, Wu T, Clark P, Xu D, Mathieu MC et al. Prostacyclin antagonism reduces pain and inflammation in rodent models of hyperalgesia and chronic arthritis. J Pharmacol Exp Ther. 2006;319:1043-50.
  • 39. Molloy ES, Morgan MP, McDonnell B, O'Byrne J, McCarthy GM. BCP crystals increase prostacyclin production and upregulate the prostacyclin receptor in OA synovial fibroblasts: potential effects on mPGES1 and MMP-13. Osteoarthritis Cartilage. 2007;15:414-20.
  • 40. Claveau D, Sirinyan M, Guay J, Gordon R, Chan CC, Bureau Y et al. Microsomal prostaglandin E synthase1 is a major terminal synthase that is selectively upregulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvantinduced arthritis model. J Immunol. 2003;170:4738- 44.
  • 41. Brodie MJ, Hensby CN, Parke A, Gordon D. Is prostacyclin in the major pro-inflammatory prostanoid in joint fluid? Life Sci. 1980;27:603-8.
  • 42. Timur UT, Caron MMJ, Bastiaansen-Jenniskens YM, Welting TJM, van Rhijn LW, van Osch G et al. Celecoxib-mediated reduction of prostanoid release in Hoffa's fat pad from donors with cartilage pathology results in an attenuated inflammatory phenotype. Osteoarthritis Cartilage. 2018;26:697-706.
  • 43. Tsavalas N, Karantanas AH. Suprapatellar fat-pad mass effect: MRI findings and correlation with anterior knee pain. AJR Am J Roentgenol. 2013;200:W291-6.
  • 44. Eckstein F, Collins JE, Nevitt MC, Lynch JA, Kraus VB, Katz JN et al. Brief Report: cartilage thickness change as an imaging biomarker of knee osteoarthritis progression: data from the foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium. Arthritis Rheumatol. 2015;67:3184-9.
  • 45. Wang X, Cicuttini F, Jin X, Wluka AE, Han W, Zhu Z et al. Knee effusion-synovitis volume measurement and effects of vitamin D supplementation in patients with knee osteoarthritis. Osteoarthritis Cartilage. 2017;25:1304-12.
  • 46. Davis JE, Ward RJ, MacKay JW, Lu B, Price LL, McAlindon TE et al. Effusion-synovitis and infrapatellar fat pad signal intensity alteration differentiate accelerated knee osteoarthritis. Rheumatology (Oxford). 2019;58:418-26.
  • 47. Zhang Y, Nevitt M, Niu J, Lewis C, Torner J, Guermazi A et al. Fluctuation of knee pain and changes in bone marrow lesions, effusions, and synovitis on magnetic resonance imaging. Arthritis Rheum. 2011;63:691-9.
  • 48. Yusuf E, Kortekaas MC, Watt I, Huizinga TW, Kloppenburg M. Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review. Ann Rheum Dis. 2011;70:60-7.
  • 49. Baker K, Grainger A, Niu J, Clancy M, Guermazi A, Crema M et al. Relation of synovitis to knee pain using contrast-enhanced MRIs. Ann Rheum Dis. 2010;69:1779-83.
  • 50. Villanueva I, del Mar Guzman M, Javier Toyos F, Ariza-Ariza R, Navarro F. Relative efficiency and validity properties of a visual analogue vs a categorical scaled version of the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index: Spanish versions. Osteoarthritis Cartilage. 2004;12:225-31.
  • 51. Papathanasiou G, Stasi S, Oikonomou L, Roussou I, Papageorgiou E, Chronopoulos E et al. Clinimetric properties of WOMAC Index in Greek knee osteoarthritis patients: comparisons with both selfreported and physical performance measures. Rheumatol Int. 2015;35:115-23
Cukurova Medical Journal-Cover
  • ISSN: 2602-3032
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1976
  • Yayıncı: Çukurova Üniversitesi Tıp Fakültesi
Sayıdaki Diğer Makaleler

Fokal karaciğer lezyonlarının saptanmasında single shot fast spin echo, Fiesta ve Propeller T2A MR sekanslarının etkinliklerinin karşılaştırılması

Mehmet AKIN, Cengiz YILMAZ, Bozkurt GÜLEK, Ömer KAYA, Okan DILEK, Gökhan SÖKER

Konjenital batın ön duvarı defektleri: 4 yıllık olgu serisi

Mehmet SATAR, Ahmet İbrahim KURTOĞLU, Şeref Selçuk KILIÇ, Çiğdem AKCABAY, Hacer YAPICIOĞLU, Ferda ÖZLÜ, Şerif HAMİTOĞLU, Nejat NARLI

Beta talasemi minör ve demir eksikliği anemisinin ayırıcı tanısında eritrosit indekslerinin tanısal doğruluk testlerinin değerlendirilmesi: ön çalışma raporu

Tevfik BALCI, Durmuş AYAN, Cevdet TÜRKYÜREK, Ergül BAYRAM

Hepatoselüler karsinomda serum mikroRNA-122'nin önemi

Engin ONAN, Hikmet AKKIZ, Macit Umran SANDIKCI, Oğuz ÜSKÜDAR, Agah Bahadır ÖZTÜRK

Tek seansta ventral herni onarımı ile birlikte pannikülektomi de uygulanmalı mı?

Serdar KIRMIZI, Emil HÜSEYİNOĞLU

Türkiye'deki Roman toplumunun ağız diş sağlığı durumunun değerlendirilmesi

Elif KOÇAK, Bahar ALKAYA

Tıpta uzmanlık alanlarının toplumsal cinsiyet açısından değerlendirilmesi

Necla YILMAZ, Ahmet ALKAN, Ayşe Gülen ERTÜMER, Zeynep KUH

Pediatrik maksillofasiyal travmaların epidemiyolojik analizi

İbrahim TABAKAN, Ömer KOKAÇYA, Cengiz ESER, Eyüp GENCEL

Total diz ve kalça protezi ameliyatı geçiren hastalarda kalıcı üriner kateteri çıkarmadan önce klemplemenin idrar miktarına ve miksiyon süresine etkisi

Duygu BAYRAKTAR, Leyla KHORSHİD

Siklofosfamide maruz kalmış sıçanların dilaltı bezi üzerine kurkuminin etkisi

Ahmad YAHYAZADEH